Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins.
| Autor: | Mühlebach, T. J.1, Gabay, J.2, Nathan, C. F.2, Erny, C.1, Dopfer, G.3, Schroten, H.4, Wahn, V.4, Seger, R. A.1 |
|---|---|
| Zdroj: | Clinical & Experimental Immunology. May1992, Vol. 88 Issue 2, p203-206. 4p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|